Bioscience company receives $15 million in funding

The funding will support the international commercial expansion of the FebriDx rapid point-of-care test.


  • By
  • | 6:34 p.m. February 5, 2020
Courtesy. Dr. Robert Sambursky, president and CEO of Lumos Diagnostics. Lumos Diagnostics announced the closing of $15 million in Series A funding from Planet Innovation.
Courtesy. Dr. Robert Sambursky, president and CEO of Lumos Diagnostics. Lumos Diagnostics announced the closing of $15 million in Series A funding from Planet Innovation.
  • Manatee-Sarasota
  • Share

A bioscience company born in Lakewood Ranch 15 years ago that, more recently, merged with a California firm, has hit a major milestone: it received $15 million in funding. 

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content